Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Exercise reduces risk of heart disease in postmenopausal women

Exercise reduces risk of heart disease in postmenopausal women

March 18, 2008

Aerobic exercise significantly decreased the chemical imbalances that can lead to heart disease and stroke in postmenopausal women according to a study in the spring issue of the Journal of Women and Aging.

Estrogen is known to reduce the chemical imbalances that can lead to cardiovascular diseases such as coronary heart disease and stroke in postmenopausal women. However, recent studies have reported detrimental effects of long-term use of hormone replacement therapy (HRT) or estrogen replacement therapy, including an increased risk of stroke, heart attack and breast cancer. Faced with these potential consequences, more women are turning to exercise as a natural way to combat postmenopausal effects.




The study found that HRT users and non-HRT users benefited equally from the exercise.

"Given the controversy with HRT, postmenopausal women can now use aerobic exercise training to lower chemical stress levels, thus reducing another risk factor for chronic disease," said Michael D. Brown, Ph.D., a co-author and associate professor of kinesiology at Temple University's College of Health Professions.

The chemical imbalance or stress - called oxidative stress - occurs when oxidants, harmful chemicals that damage tissue and cells, outnumber antioxidants in the body. Antioxidants protect cells and tissues against oxidants. Postmenopausal women have higher levels of oxidative stress.

A single bout of intense exercise acutely raises oxidative stress by increasing the production of oxidants. Conversely, regular exercise of moderate intensity appears to reduce oxidative stress through an adaptive process that increases antioxidant activity.

"Regardless of your hormone replacement therapy status, regular physical activity is a good way to not only decrease postmenopausal symptoms, but also to reduce the risk of cardiovascular disease, the leading cause of death of American women," said study co-author Nicola Fenty-Stewart, Ph.D., also with Temple's College of Health Professions.

"The similar response of the two groups suggests that aerobic exercise training is a powerful therapy that can potentially serve as a way for women to observe the beneficial effects of exercise," she said.

The study followed 48 sedentary postmenopausal women (21 on HRT and 27 not on HRT) through an exercise program consisting of three supervised sessions of aerobic exercise per week for 24 weeks. Participants were between 50 and 75 years of age and were postmenopausal for at least two years.

Since changes in habitual dietary intake could influence oxidative stress levels, qualified subjects were stabilized for six weeks on the American Heart Association Step I diet, which is low in saturated and trans fat, and rich in fruits, vegetables, whole grains and fat-free and low-fat dairy products, Brown said.

Weight loss was limited to 5 percent or less of the women's initial body weight in order to determine the independent effects of aerobic exercise training on oxidative stress, not the effect of exercise and weight loss on oxidative stress.

The HRT users and non-users both experienced an 11 to 18 percent drop in plasma thiobarbituric acid reactive substances, an indicator of oxidative stress.

There were also decreases in body mass index and total body fat, and a significant increase in VO2 max (maximal oxygen uptake or aerobic capacity) in both HRT users and non-users after the exercise intervention, Brown said.

"Exercise was able to reduce oxidative stress levels in these women regardless of whether or not they were using estrogen replacement. In addition, the women did not lose large amounts of body weight or fat," Brown said.

"No one is too old to begin an exercise program, but it is imperative to consult your physician before taking part in any exercise program. It is important to start off slow and build your program to your comfort level. Exercising is not difficult. You just have to want to do it," Brown added.

Temple University



Related Postmenopausal Women Current Events and Postmenopausal Women News Articles Postmenopausal Women Current Events and Postmenopausal Women News RSS Postmenopausal Women Current Events and Postmenopausal Women News RSS
Mayo researchers find robotic repair for vaginal prolapse has significant benefits
New Mayo Clinic research has found that robotic surgery for vaginal prolapse dramatically reduces patient hospital stay and recovery time.

Postmenopausal women with higher testosterone levels
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels.

Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman
Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women.

Novel, soy-based SE5-OH containing Natural S-equol supplement reduced hot flash frequency by nearly 59 percent
SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women.

Researchers believe hormone therapy should not be stopped prior to mammograms
Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings.

Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance
The largest study in the world of treatments for post menopausal, hormone positive breast cancer has shown that patients who continue to take exemestane or tamoxifen do significantly better than patients who start to take one or other drug (or tamoxifen followed exemestane) but then stop.

Postmenopausal women benefit from endurance training as much as younger women
Marilyn Graham was 56 when she signed up for a grueling hour of cycling each morning for 12 weeks, occasionally decked out in a mask, a heart monitor and a bag of intravenous fluid and subjected to needle pricks to obtain blood samples.

Seizure drug enhances sleep for women with hot flashes
Gabapentin, a drug initially used to treat seizures, improves sleep quality in menopausal women with hot flashes, University of Rochester Medical Center researchers report online and in the September issue of the Journal of Women's Health.

Buyer beware: Estrogen supplements not as effective as claimed
Dietary supplements claiming to help postmenopausal women with bone health may not be doing what they say, according to new research from Purdue University.

Low-dose estrogen shown safe and effective for metastatic breast cancer
When estrogen-lowering drugs no longer control metastatic breast cancer, the opposite strategy might work. Raising estrogen levels benefited 30 percent of women whose metastatic breast cancer no longer responded to standard anti-estrogen treatment.
More Postmenopausal Women Current Events and Postmenopausal Women News Articles
Treatment of the Postmenopausal Woman: Basic and Clinical Aspects, 3rd Edition

Treatment of the Postmenopausal Woman: Basic and Clinical Aspects, 3rd Edition
by Rogerio A. Lobo (Editor)

For anyone who treats postmenopausal women, this latest edition of Rogerio Lobo's classic work combines the best from two well-known references: Menopause, and the second edition of Treatment of the Postmenopausal Woman. By adding significant discussions of the basic science behind menopause, it is possible to objectively assess the clinical value and limitations of current approaches to treatment and provide a basis and rationale for strategies that will result in better individualized and specialized care. Not only does the third edition discuss diagnosis and treatment of menopause but it covers biological, anatomical, physiological, pathobiological, and pharmacological aspects as well bringing together, in one source, all of the information needed to understand and treat postmenopausal...

Femgest Progesterone 2/2 fl oz Cream

Femgest Progesterone 2/2 fl oz Cream
by Home Health

An organically based form of progesterone cream designed for women of all ages, FemGest provides a gentle, holistic approach to your body's need for balance. Featuring progesterone combined with soothing aloe vera and grapefruit extract, FemGest is ideal for those times when you want a supportive, soothing cream that harmonizes with your unique nature.

Healthy Aging Nutraceuticals Osteo Support 120 Tab

Healthy Aging Nutraceuticals Osteo Support 120 Tab
by Healthy Aging Nutraceuticals

Healthy bones need more than just calcium, and this is the best product we have found. A combination mineral, nutrient and herbal formulation, Osteo Support contains all the supplements you need to build and protect bones. We use it most often for bone injuries and for pre- and postmenopausal women who want a good quality calcium supplement.

  Assessment of the body mass index and selected physiological parameters in pre- and post-menopausal women [An article from: HOMO - Journal of Comparative Human Biology]
by M. Skrzypczak (Author), A. Szwed (Author)

This digital document is a journal article from HOMO - Journal of Comparative Human Biology, published by Elsevier in . The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
The main purpose of this paper is to describe the variability of the body mass index (BMI) and selected physiological parameters (serum glucose, total serum cholesterol, systolic and diastolic blood pressure) in women before and after menopause. The empirical basis for the assessment is the material obtained in cross-sectional studies carried out in the years 1998-2001 in a group of 2204 women aged 35-65 years, residents of the Wielkopolska region, Poland. The results indicate that hormonal...

  Close follow-up OK for many small ovarian cysts. (Asymptomatic Postmenopausal Women).: An article from: Family Practice News
by Sherry Boschert (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2003. The length of the article is 611 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Close follow-up OK for many small ovarian cysts. (Asymptomatic Postmenopausal Women).
Author: Sherry Boschert
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2003
Publisher: International Medical News Group
Volume: 33 Issue: 3 Page: 41(1)

Distributed by Thomson...

  Primary Hyperparathyroidism of Post-Menopausal Women: Prospective Population-Based Case-Control Analysis on Prevalence, Clinical Findings and Treatment ... Summaries of Uppsala Dissertations, 820)
by Ewa Lundgren (Author)



  Audio Digest: Obstetrics/gynecology: Decreasing Cardiovascular Risk in Postmenopausal Women (Vol. 48, Issue 7, April 7, 2001)
by MD Robert T. Faillace (Author)

Atherogenesis. Gender-related issues. Non-modifiable/modifiable risk factors. High-sensitivity c-reactive protein. The role of exercise in prevention of cardiovascular disease. Lipid-lowering therapy (statins). Hyperlipidemia. Hormone and non-hormone therapy.

  Investigational drug built BMD in postmenopausal women.(GYNECOLOGY): An article from: OB GYN News
by Unavailable (Author)

This digital document is an article from OB GYN News, published by International Medical News Group on May 1, 2009. The length of the article is 532 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Investigational drug built BMD in postmenopausal women.(GYNECOLOGY)
Author: Unavailable
Publication: OB GYN News (Magazine/Journal)
Date: May 1, 2009
Publisher: International Medical News Group
Volume: 44 Issue: 7 Page: 24(1)

Distributed by Gale, a part of Cengage...

  Association of a -1997G [right arrow] T polymorphism of the collagen I[alpha]1 gene with bone mineral density in postmenopausal Japanese women.: An article from: Human Biology
by Yoshiji Yamada (Author), Fujiko Ando (Author), Naoakira Niino (Author), Hiroshi Shimokata (Author)

This digital document is an article from Human Biology, published by Thomson Gale on February 1, 2005. The length of the article is 4926 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the author: KEY WORDS: BONE MINERAL DENSITY, COLLAGEN I[alpha]1, COLA1A, OSTEOPOROSIS, JAPAN.

Citation Details
Title: Association of a -1997G [right arrow] T polymorphism of the collagen I[alpha]1 gene with bone mineral density in postmenopausal Japanese women.
Author: Yoshiji Yamada
Publication: Human Biology (Magazine/Journal)
Date: February 1, 2005
Publisher: Thomson Gale
Volume: 77 ...

Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women [An article from: Biological Psychology]

Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women [An article from: Biological Psychology]
by K.A. Matthews (Author), J.F. Owens (Author), K. Salomon (Author), K.F Harris (Author)

This digital document is a journal article from Biological Psychology, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
Epidemiological and psychophysiological data suggest that groups that differ in reproductive hormones and stress responses also differ in risk for cardiovascular disease. To evaluate the effects of hormone therapy on women's cardiovascular responses to laboratory stressors, 89 healthy postmenopausal women were tested twice, before and after exposure for about 8 weeks to one of the five conditions: placebo, Estratab (primarily estrone), Estratab plus Prometrium (micronized progesterone), Estratab plus Provera...

© 2009 BrightSurf.com